ask="51.50"
ask_size="100"
average_daily_volume="380289"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="+0.20"
change_from_200_day_moving_average="-3.85"
change_from_50_day_moving_average="-1.24"
change_from_52_week_high="-14.75"
change_From_52_week_low="17.06"
change_in_percent="+0.43%"
close="46.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.75"
high_52_weeks="60.98"
last_trade_date="2/10/2017"
last_trade_price="46.23"
last_trade_size="10069"
last_trade_time="4:00pm"
low="45.67"
low_52_weeks="29.17"
market_capitalization="1.25B"
moving_average_200_day="50.08"
moving_average_50_day="47.47"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="46.19"
pe_ratio="5.17"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-7.69%"
percent_change_from_50_day_moving_average="-2.62%"
percent_change_from_52_week_high="-24.19%"
percent_change_from_52_week_low="+58.48%"
previous_close="46.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.09"
price_per_sales="3.24"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.16"
stock_exchange="NMS"
symbol="FPRX"
volume="273828"
weeks_range_52="29.17 - 60.98"
